Overview
- 2 FDA inspections are on record.
- 2 inspections produced a Form 483.
- The most recent recorded inspection date is 2021-01-27.
At a glance
Inspections
2
Form 483s
2
EIRs
1
Last outcome
Form 483
Inspection history
FDA inspections on record, most recent first.
| Inspection | Category | Outcome | Form 483 |
|---|---|---|---|
| 4 Jan 2021 – 27 Jan 2021 | Human Drugs | 483 | On file |
| 19 Jan 2016 – 17 Feb 2016 | Human Drugs | 483 | View 483 → |
Observations on record
Form 483 observations cited at this site, most recent first.
17 Feb 2016
21 CFR 312.56(a)
Monitoring investigations
Cited by Lakecha N Lewis, Phillip D Kronstein, Ni A Khin
17 Feb 2016
21 CFR 312.50
General responsibilities of sponsors
Cited by Lakecha N Lewis, Phillip D Kronstein, Ni A Khin
Investigators
FDA investigators tied to this site in the record.
Recurring citations
CFR citation patterns observed across this site's inspections.
| Citation | What it covers | Cited |
|---|---|---|
| 21 CFR 312.50 | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 312.56(a) | Cited across public-safe Form 483 observations | 1x |
Full site report
Get the verbatim findings behind Acadia Pharmaceuticals, Inc's 2 Form 483s
Verbatim observations and recurring CFR citations, so your team knows what this site gets cited for.
- The site's full inspection history, with every Form 483 and its outcome
- Warning letters and recalls tied to the company behind it
- Whether recurring CFR citations get closed out or repeat